Laboratory Corporation of America Holdings (LH)

Gross profit margin

Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019
Gross profit (ttm) US$ in thousands 3,489,500 4,142,400 4,177,400 4,277,700 4,535,900 4,436,600 4,935,900 5,258,200 5,624,300 6,154,200 6,328,100 5,823,800 4,952,800 3,868,600 3,126,500 3,190,800 3,252,500 3,204,200 3,176,800 3,187,100
Revenue (ttm) US$ in thousands 12,901,700 15,811,000 15,621,000 15,510,300 15,632,000 13,745,500 14,941,300 15,859,000 16,120,900 16,554,600 16,388,100 15,316,200 13,978,500 12,442,100 11,474,500 11,587,400 11,554,800 11,388,900 11,291,700 11,276,300
Gross profit margin 27.05% 26.20% 26.74% 27.58% 29.02% 32.28% 33.04% 33.16% 34.89% 37.18% 38.61% 38.02% 35.43% 31.09% 27.25% 27.54% 28.15% 28.13% 28.13% 28.26%

December 31, 2023 calculation

Gross profit margin = Gross profit (ttm) ÷ Revenue (ttm)
= $3,489,500K ÷ $12,901,700K
= 27.05%

Laboratory Corp. Of America Holdings' gross profit margin has shown a declining trend over the past few quarters. The Q4 2023 gross profit margin of 27.67% is lower compared to the previous quarter, indicating a decrease in profitability. This downward trend started in Q1 2023, following a peak gross profit margin of 33.16% in Q1 2022.

The decreasing gross profit margins could be a potential concern as it may indicate challenges in managing production costs or pricing strategies. Further analysis of the company's cost structure and revenue generation is recommended to identify the specific factors contributing to the declining trend in gross profit margin.


Peer comparison

Dec 31, 2023

Company name
Symbol
Gross profit margin
Laboratory Corporation of America Holdings
LH
27.05%
Fulgent Genetics Inc
FLGT
36.12%
Quest Diagnostics Incorporated
DGX
31.88%
RadNet Inc
RDNT
93.06%